Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Assets
Loans held for investment	$ 339,273,538	$ 196,984,566
Current expected credit loss reserve	(3,940,939)	(134,542)
Loans held for investment at carrying value, net	335,332,599	196,850,024
Cash	5,715,827	80,248,526
Interest receivable	1,204,412	197,735
Other receivables and assets, net	1,018,212	874,170
Total Assets	343,271,050	278,170,455
Liabilities
Revolving loan	58,000,000
Dividend payable	13,618,591	4,537,924
Management and incentive fees payable	3,295,600	802,294
Interest reserve	1,868,193	6,636,553
Related party payables	1,397,515	1,902,829
Accounts payable and other liabilities	1,058,128	212,887
Total Liabilities	79,238,027	14,092,487
Commitments and contingencies (Note 8)
Stockholders’ equity
Common stock, par value $0.01 per share, 100,000,000 shares authorized and 17,766,936 and 17,453,553 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively	176,859	173,551
Additional paid-in-capital	268,995,848	264,081,977
Accumulated earnings (deficit)	(5,139,684)	(177,560)
Total stockholders’ equity	264,033,023	264,077,968
Total liabilities and stockholders’ equity	$ 343,271,050	$ 278,170,455